These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3048453)

  • 21. [Prostaglandin analogs for the treatment of peptic ulcer].
    Mutoh H
    Nihon Rinsho; 1984 Jan; 42(1):125-9. PubMed ID: 6371306
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostaglandin therapy in a case of refractory stress ulcer bleeding.
    Groeger JS; Dazza SJ; Carlon GC; Turnbull AD; Pierri MK; Howland WS
    Crit Care Med; 1982 Jul; 10(7):486-7. PubMed ID: 7083876
    [No Abstract]   [Full Text] [Related]  

  • 23. Omeprazole to prevent recurrent bleeding after endoscopic treatment of ulcers.
    Libby ED
    N Engl J Med; 2000 Aug; 343(5):358-9. PubMed ID: 10922427
    [No Abstract]   [Full Text] [Related]  

  • 24. Controlled trial of arbaprostil in bleeding peptic ulcer.
    Langman MJ; Somerville KW
    Br Med J (Clin Res Ed); 1985 Nov; 291(6505):1351. PubMed ID: 3933664
    [No Abstract]   [Full Text] [Related]  

  • 25. [New prostaglandin derivatives--progress in ulcer therapy?].
    Schepp W
    Fortschr Med; 1986 Dec; 104(3):913-7. PubMed ID: 2881863
    [No Abstract]   [Full Text] [Related]  

  • 26. [What is the current therapeutic role of omeprazole in gastroduodenal ulcer disease?].
    Gisbert JP; Boixeda D; Martín de Argila C
    Rev Esp Enferm Dig; 1997 Feb; 89(2):116-23. PubMed ID: 9115818
    [No Abstract]   [Full Text] [Related]  

  • 27. Future treatment of peptic ulcers.
    Calam J
    Scand J Gastroenterol Suppl; 1985; 117():47-53. PubMed ID: 2869578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoprotection of gastroduodenal mucous membrane with analogues of prostaglandins.
    Lauritsen K; Laursen LS; Rask-Madsen J
    Recenti Prog Med; 1989 Jun; 80(6):344-52. PubMed ID: 2672199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drugs in gastroenterology.
    Friedman G
    Mt Sinai J Med; 1985 Jun; 52(6):484-9. PubMed ID: 3875031
    [No Abstract]   [Full Text] [Related]  

  • 30. [Misoprostol: prevention of ulcers caused by NSAID].
    Matzen P; Rask Madsen J
    Ugeskr Laeger; 1996 Aug; 158(34):4782-5. PubMed ID: 8801690
    [No Abstract]   [Full Text] [Related]  

  • 31. [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA
    Sov Med; 1991; (3):39-43. PubMed ID: 1909055
    [No Abstract]   [Full Text] [Related]  

  • 32. Peptic ulcer treatment now and tomorrow.
    Langman MJ
    J Clin Gastroenterol; 1987; 9 Suppl 2():2-6. PubMed ID: 3624833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled trial of arbaprostil in bleeding peptic ulcer.
    Lauritsen K; Laursen LS; Havelund T; Bytzer P; Rask-Madsen J
    Br Med J (Clin Res Ed); 1985 Oct; 291(6502):1093. PubMed ID: 3931810
    [No Abstract]   [Full Text] [Related]  

  • 34. [Various problems on refractory peptic ulcers; progress of drug therapy and changes in the concept of peptic ulcer].
    Ishimori A; Kawamura T
    Nihon Rinsho; 1988 Jan; 46(1):146-51. PubMed ID: 3373747
    [No Abstract]   [Full Text] [Related]  

  • 35. Uncomplicated peptic ulcer disease. An overview of formation and treatment principles.
    Ziller SA; Netchvolodoff CV
    Postgrad Med; 1993 Mar; 93(4):126-8, 131-2, 137-40. PubMed ID: 8095330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rioprostil: a new prostaglandin for treatment of peptic ulcer disease and NSAID-induced digestive lesions. Proceedings of an international symposium. Wiesbaden, 11-13 June 1987.
    Scand J Gastroenterol Suppl; 1989; 164():1-253. PubMed ID: 2510250
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of peptic ulcer].
    Siurala M
    Duodecim; 1978; 94(12):802-9. PubMed ID: 28938
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The mechanism of action of new drugs in ulcer therapy].
    Simon B; Fromm T; Kather H; Kommerell B
    Verh Dtsch Ges Inn Med; 1978; (84):984-7. PubMed ID: 742166
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of NSAID-associated peptic ulcer disease.
    Melcarne L; García-Iglesias P; Calvet X
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.